Marksans Pharma Limited (NSE:MARKSANS)
258.00
-0.60 (-0.23%)
Jul 31, 2026, 3:29 PM IST
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 117.07 billion as of July 31, 2026. Its market cap has increased by 9.35% in one year.
Market Cap
117.07B
Enterprise Value
110.91B
Revenue
29.51B
Ranking
n/a
PE Ratio
28.02
Stock Price
258.00
ChartMarket Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 117.07B, an increase of 3,106.16%. That is a compound annual growth rate of 19.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 117.07B | 43.30% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.78T |
| Divi's Laboratories | 2.08T |
| Apollo Hospitals Enterprise | 1.29T |
| Cipla | 1.19T |
| Park Medi World | 126.40B |
| Indegene | 123.99B |
| Metropolis Healthcare | 121.33B |
| Blue Jet Healthcare | 118.53B |